The latest report by IMARC Group, titled “Clinical Laboratory Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global clinical laboratory services market is expected to grow at a CAGR of 6.1% during 2022-2027. Clinical laboratory services are an essential part of the healthcare industry as they are used for the assessment, diagnosis, treatment, prevention and management of patients. They assist in the biological, microbiological, serological, chemical, immune-hematological, biophysical, cytological, pathological, and hematological examination of materials obtained from the human body. They also determine, measure and describe the presence or absence of various substances or organisms in the body. Besides this, clinical laboratories offer data and resources through diagnostic and test results ranging from blood tests to genetic analysis. In recent years, various medical organizations and healthcare institutions have been using software programs and computers to improve accessibility to report results and billing information.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. 

Global Clinical Laboratory Services Market Trends: 

The market is primarily driven by the growing instances of chronic diseases such as cancer and diabetes. Clinical laboratory services maintain reliable and correct test results that enable doctors to form relevant clinical and diagnostic decisions across the healthcare system. This is also increasing the demand for early and accurate diagnosis of diseases, thereby fueling the growth of the market. Besides this, the introduction of more accurate and advanced products, such as companion diagnostics, biochips and microarrays, is escalating the demand for clinical laboratory services. In addition, the rising healthcare expenditure and inflating disposable incomes of individuals are also propelling the market growth. Furthermore, advancements in clinical diagnostics, the rising adoption of digital pathology platforms, and the increasing preference for comprehensive health checkups offered by clinical laboratories are expected to create opportunities for the market in the upcoming years.

Market Summary: 

• Based on the test type, the market has been segmented into human and tumor genetics, clinical chemistry, medical microbiology and cytology, and others.
• On the basis of the service provider, the market has been classified into hospital-based, stand-alone, and clinic-based laboratories
• The market has been categorized based on the application into bioanalytical and lab chemistry, toxicology testing, cell and gene therapy related, preclinical and clinical trial related, drug discovery and development related, and other services.
• Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
• The competitive landscape of the market has been examined, with some of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Charles River Laboratories, F. Hoffmann-La Roche Limited, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG), and Thermo Fisher Scientific Inc.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800